Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy

Nature Clinical Practice Rheumatology

Volumn 3, Issue 7, 2007, Pages 414-419

  van Ingen, Jakko ^a,b   Boeree, Martin ^a   Janssen, Matthijs ^c   Ullmann, Erik ^c   de Lange, Wiel ^a   de Haas, Petra ^b   Dekhuijzen, Richard ^a   van Soolingen, Dick ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CLARITHROMYCIN; ETANERCEPT; ETHAMBUTOL; FLUTICASONE PROPIONATE; METHOTREXATE; NAPROXEN; RIFAMPICIN; SALBUTAMOL; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ARTICLE; ASBESTOSIS; BACTERIUM CULTURE; BERYLLIOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUNG CAVITATION; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MALAISE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM SZULGAI; MYCOSIS; NIGHT SWEAT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SILICOSIS; SPUTUM EXAMINATION; THORAX DRAINAGE; THORAX RADIOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; BRONCHOALVEOLAR LAVAGE FLUID; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; RECEPTORS, TUMOR NECROSIS FACTOR; RIFAMPIN; SPUTUM; THORACOTOMY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447118413     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0538     Document Type: Article

References (16)

1. American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156: S1-S25
2. Zhang Q et al. (2002) Pseudoepidemic due to a unique strain of Mycobacterium szulgai: Genotypic, phenotypic, and epidemiological analysis. J Clin Microbiol 40: 1134-1139
3. Jeong YJ et al. (2004) Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: Comparison of thin-section CT and histopathologic findings. Radiology 231: 880-886
4. Ishige I et al. (1999) Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354: 120-123
5. Doty JD et al. (2005) Treatment of sarcoidosis with infliximab. Chest 127: 1064-1071
6. Gonzalez-Lopez MA et al. (2006) Development of sarcoidosis during etanercept therapy. Arthritis Rheum 55: 817-820
7. Saliu OY et al. (2006) Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis 194: 486-492
8. Gardam MA et al. (2003) Anti-tumour necrosis factor agents and tuberculosis risk: Mechanisms of action and clinical management. Lancet Infect Dis 3: 148-155
9. Wallis RS et al. (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38: 1261-1265
10. Mufti AH et al. (2005) Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy: Case report and review of infectious complications associated with tumor necrosis factor α use. Diagn Microbiol Infect Dis 53: 233-238
11. Phillips K et al. (2002) Experience with etanercept in an academic medical centre: Are infection rates increased? Arthritis Rheum 47: 17-21
12. Wallis RS (2005) Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 41: 201-208
13. Garcia Vidal C et al. (2005) Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40: 756-759
14. Matsumoto T (2006) Infliximab for rheumatoid arthritis in a patient with tuberculosis. N Engl J Med 355: 740-741
15. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society (2000) Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 55: 210-218
16. Benator DA et al. (1997) Mycobacterium szulgai infection of the lung: Case report and review of an unusual pathogen. Am J Med Sci 313: 346-351.